'Excessive' Atty Fee Bid In Ranbaxy MDL Slashed By $36M
A Boston federal judge has cut $36 million from an "excessive" fee request by attorneys for two classes of plaintiffs who settled multidistrict antitrust claims against Ranbaxy Pharmaceuticals for $485 million....To view the full article, register now.
Already a subscriber? Click here to view full article